Pierre-Olivier Goineau, co-founder and chief operating officer of the oncology company Erytech Pharma SA, has been reelected chair of the board of directors of France Biotech, an association of life science entrepreneurs. He is joined on the board by three new members: Sarah Ankri, chief financial officer of Theraclion SA; Hervé Balusson, chief executive of the OLMIX Group and Damian Marron, managing director of TxCell SA.
Before co-founding Erytech, Mr Goineau was a senior consultant at KPMG in Lyons, where he was in charge of the health division. He has a post-graduate degree in management science and a Master’s degree in pharmaceutical industry management from the Ecole universitaire de management (IAE) in Lyon.
France Biotech announced the appointments on 17 June 2014.
Copyright 2014 Evernow Publishing Ltd